VIRAL HEPATITIS B IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES (ОVERVIEW)
https://doi.org/10.22625/2072-6732-2017-9-4-24-30
##article.abstract##
The review presents current data on the role of viral hepatitis B in on-cohematological patients. Possible ways of infection, prophylaxis of infection and activation of hepatitis B in this category of patients are considered. Specific features of the course of hepatitis B in various clinical situations are described: against the background of other viral infections and in the conduct of specific anti-leukemia therapy. The need to identify occult (occult) hepatitis in donors and patients with hemoblastosis is emphasized and methods for its detection are considered.
##article.authors.about##
V. N. Chebotkevich
Russian Science Research Institute of Hematology and Transfusiology.
Saint-Petersburg.
Saint-Petersburg.
S. S. Bessmeltsev
Russian Science Research Institute of Hematology and Transfusiology.
Saint-Petersburg.
Saint-Petersburg.
V. V. Danilchenko
Russian Science Research Institute of Hematology and Transfusiology.
Saint-Petersburg.
Saint-Petersburg.
E. I. Kajtandzhan
Russian Science Research Institute of Hematology and Transfusiology.
Saint-Petersburg.
Saint-Petersburg.
V. V. Burylev
Russian Science Research Institute of Hematology and Transfusiology.
Saint-Petersburg.
Saint-Petersburg.
E. E. Kiseleva
Russian Science Research Institute of Hematology and Transfusiology.
Saint-Petersburg.
Saint-Petersburg.
A. V. Chechetkin
Russian Science Research Institute of Hematology and Transfusiology.
Saint-Petersburg.
Saint-Petersburg.
##submission.citations##
1. Hepatitis B. Fact sheet WHO, July 2017. – Available from: http://www.who.int/mediacentre/factsheets/fs204/ru/. [cited 2017 Aug30].
2. Bessmeltsev S.S., Abdulkadyrov K.M. Ultrasonic diagnostics in hematological practice. Saint-Petersburg: «KN»; 1997 (In Russian).
3. Bessmeltsev S.S., Abdulkadyrov K.M. Multiple Myeloma: Guidelines for Physicians. Moscow: МК, 2016 (In Russian).
4. Bessmeltsev S.S., Romanenko N.A. Anemia in tumorous diseases of the blood system: a guide for doctors: Guidelines for Physicians. Moscow: Special Publishing House of Medical Books, 2017 (In Russian).
5. Bessmeltsev S.S., Abdulkadyrov K.M. Vestnik Gematologii. 2006; 2 (2): 5-10 (In Russian).
6. Davydov M.I., Dmitrieva N.V. Infections in oncology. Moscow: Practical medicine, 2009. Poddubnaja I.V. Infection in patients with hematological malignancies; p. 114-23 (In Russian).
7. Bubnova L.N., Matveeva T.A., Berkos M.V. et al. Transfuziologija. 2016; 17 (2), Suppl. 1: 9-10 (In Russian).
8. Isakov V.A., Arhipova E.I., Isakov D.V. Herpesvirus infections. Saint-Petersburg: Publishing house SpetsLit; 2013 (In Russian).
9. Kornienko M.N., Rybalkina T.N., Karazhas N.V.et al. Jepidemiologija i infekcionnye bolezni. 2015; 20 (6): 33-8 (In Russian).
10. Chechetkin A.V., Danilchenko V.V., Makeev A.B. et al. Zhurnal infektologii. 2016; 8 (2), Supply: 102 (In Russian).
11. Tarasenko O.A., Gukasjan I. A., Sobolevskaja L.V., ChernenkoT.V. Spravochnik zavedujushhego KDL. 2011; 3: 3-8 (In Russian).
12. Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV and HCV infections among antibody-negative blood donors by nucleic acid amplification testing. N. Engl. Med.2004 Aug; 351 (8): 760-8.
13. Vermeulen M, Coleman C, Walker E, et al. Transmission of occult HBV infection by ID-NAT screened blood. Vox Sang. 2014; 107 (Suppl. 1): 146-7.
14. Beljakova V.V. Sovershenstvovanie laboratornogo testirovanija dlj aobespechenija virusnoj bezopasnosti allogennyh gemokomponentov [Improving laboratory testing to ensure the viral safety of allogeneic hemocomponents] [author‘s abstract]. Moscow (Russia), 2015. 24 р. (In Russian).
15. O’Brien SF, Fearon MA, Yi QL, et al. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. Transfusion. 2007 Oct; 47 (10): 1809-15.
16. TupolevaT.A., AbakarovR.R., Ignatova E.N. et al.Vestnik gematologii.2016; 12 (4): 56-7 (In Russian).
17. Tupoleva T.A., Romanova T.Ju., AbakarovR.R.et al. Laboratornye instrumenty obespechenija virusnoj bezopasnosti komponentov donorskoj krovi [Laboratory tools for ensuring the viral safety of donated blood components]. In: Molekuljarnaja diagnostika 2017 [Molecular diagnostics 2017]. Vol. 2. Moscow; 2017.P. 271-2 (In Russian).
18. Jesaulenko E.V., Suhoruk A.A., Ponjatishina M.V. et al. Zhurnal infektologii.2016; 8 (1): 66-72 (In Russian).
19. Gabdrahmanov I.A., Kozlov K.V., Zhdanov K.V. et al. Zhurnal infektologii. 2017; 9 (1): 107-9 (In Russian).
20. Schmeltzer P, Sherman K. Occult hepatitis B – clinical implications and treatment decisions. Dig. Dis. Sci. 2010 Dec; 55 (12): 3328-35.
21. Semenenko T.A., Jarosh P.V., Bazhenov A.I. et al. Jepidemiologija i vakcinoprofilaktika. 2012; 67: 9-14 (In Russian).
22. Feeney SA, McCaugheyС, Watt AP, et al. Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patient. J. Med.Virol. 2013 Apr; 85 (4): 597-601.
23. Westhoff TH, Jochimsen F, Schmittel A, et al. Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood. 2003 Sep; 102 (5): 1930.
24. Castillo I, Rodriguez-Inigo E, Lopez-Alcorocho JM, et al. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis В virus (HBV), single occult hepatitis С virus (HCV) and occult HBV and HCV dual infection. J. Med. Virol. 2007; 79 (3): 236-41.
25. Ostankova Ju.V., Semenov A.V. Vyjavlenie okkul›tnogo gepatita B pri nizkoj virusnoj nagruzke v perifericheskoj krovi HBsAg-negativnyh donorov krovi [Detection of occult hepatitis B with low viral load in the peripheral blood of HBsAg-negative blood donors]. In: Materialy XI s#ezda Vserossijskogo nauchnoprakticheskogo Obshhestva jepidemiologov, mikrobiologov i parazitologov «Obespecheniej epidemiologicheskogo blagopoluchija: vyzovy I reshenija» [XI Congress of the All-Russian Scientific and Practical Society of Epidemiologists, Microbiologists and Parasitologists «Ensuring Epidemiological Wellbeing: Challenges and Solutions»]. Saint-Petersburg (Russia): Research Institute of Epidemiology and Microbiology named after Pasteur, 2017. P. 310 (In Russian).
26. Dervite I, Hober D, Morel PN. Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. Engl. J. Med. 2001 Jan; 344 (1): 68-9.
27. Vento S, Cainelli F, Longhi M. Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue. Lancet Oncol. 2002 Jun; 3 (6): 333-40.
28. Ghielmini M, Schmitz SF, Cogliatti S, et al. Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK). J. Clin. Oncol.2005 Feb; 23 (4): 705-11.
29. Tsutsumi Y, Tanaka J, Kawamura T, et al. Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin’s lymphoma. Ann. Hematol. 2004 Jan; 83 (1): 58-60.
30. Qawasmi M, Samuh M, Glebe D, et al. Age-dependent decrease of anti-HBs titers and effect of booster doses using 2 different vaccines in Palestinian children vaccinated in early childhood. Hum Vaccin. Immunother. 2015; 11 (7): 1717-24.
31. Krymskij M.A., Krymskij R.M., Budanov M.V., Borisova V.N. Biofarmacevticheski jzhurnal. 2010; 2 (5): 8-15 (In Russian).
32. Semenenko T.A., Nikitina G. Ju., Jarosh L.V. et al. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2015; 17 (1): 73-8 (In Russian).
33. Ledin E.V. Jeffektivnost’ specificheskoj immunoprofilaktiki gepatita B u bol’nyh onkogematologicheskogo profilja [The effectiveness of specific immunoprophylaxis of hepatitis B in patients with hematological profile] [author’sabstract]. Moscow; 2008. 23 p. (In Russian).
34. Arrowood JR, Hayney MS. Immunization recommendations for adults with cancer. Ann Pharmacother.2002; 36 (7-8): 1219-29.
35. Poddubnaja I.V., Savchenko V.G. Russian clinical guidelines for the diagnosis and treatment of lymphoproliferative diseases. Moscow; 2016 (In Russian).
##reviewer.review.form##
##article.forCitation##
Chebotkevich V.N., Bessmeltsev S.S., Danilchenko V.V., Kajtandzhan E.I., Burylev V.V., Kiseleva E.E., Chechetkin A.V. VIRAL HEPATITIS B IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES (ОVERVIEW). Journal Infectology. 2017;9(4):24-30. (In Russ.) https://doi.org/10.22625/2072-6732-2017-9-4-24-30
##common.article.views##:
1153
JATS XML
.png)
.png)
##plugins.block.readingTools.emailThisArticle## 